Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions

G Bauer, M Elsallab… - Stem cells translational …, 2018 - academic.oup.com
The promise of stem cell (SC) therapies to restore functions of damaged tissues and organs
brings enormous hope to patients, their families, loved ones, and caregivers. However, limits …

Ethical issues and public communication in the development of cell-based treatments for COVID-19: lessons from the pandemic

L Turner, M Munsie, AD Levine, L Ikonomou - Stem cell reports, 2021 - cell.com
The significant morbidity and mortality of coronavirus disease 19 (COVID-19) prompted a
global race to develop new therapies. These include interventions using cell-or cell-derived …

[HTML][HTML] International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of …

L Ikonomou, N Cuende, M Forte, BJ Grilley, AD Levine… - Cytotherapy, 2023 - Elsevier
The field of regenerative medicine, including cellular immunotherapies, is on a remarkable
growth trajectory. Dozens of cell-, tissue-and gene-based products have received marketing …

Using A Google Web Search Analysis to Assess the Utility of ChatGPT in Stem Cell Therapy

L Chen, H Li, Y Su, Z Yang, Z He… - Stem Cells …, 2024 - academic.oup.com
Objective Since its introduction, the use of ChatGPT has increased significantly for medically
related purposes. However, current research has not captured its applications in providing …

Translating basic research into safe and effective cell-based treatments for respiratory diseases

L Ikonomou, DE Wagner, L Turner… - Annals of the American …, 2019 - atsjournals.org
Respiratory diseases, such as chronic obstructive pulmonary disease and pulmonary
fibrosis, result in severely impaired quality of life and impose significant burdens on …

Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns

J Snyder, L Turner - Regenerative medicine, 2018 - Taylor & Francis
Aim: To better understand how prospective customers interpret claims of businesses
marketing unproven stem cell products that they are engaging in research activities …

The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions

U Ogbogu, J Du, Y Koukio - BMC medical ethics, 2018 - Springer
Background Direct to consumer offerings of unproven stem cell interventions (SCIs) is a
pressing scientific and policy issue. According to media reports, providers of SCIs have …

Polish regulatory system regarding ATMP hospital exemptions

J Pachocki, F Verter - Frontiers in Immunology, 2024 - frontiersin.org
Introduction This article explains the current regulatory system in Poland regarding
Advanced Therapy Medicinal Products given under Hospital Exemptions (ATMP-HE) …

Academic physician specialists' views toward the unproven stem cell intervention industry: areas of common ground and divergence

C Smith, A Crowley, M Munsie, ES DeMartino, NP Staff… - Cytotherapy, 2021 - Elsevier
Abstract Background and Aims Premature commercialization of unproven stem cell
interventions (SCIs) has received significant attention within the regenerative medicine …

Survey of genetic counselors identifies a knowledge gap discerning properly regulated cell and gene therapy trials

LA Geiselman, L Wetherill, BH Graham, K Payne… - Cytotherapy, 2024 - Elsevier
Background and aims As cell and gene therapy (CGT) has grown in availability and scope,
more unapproved regenerative medicine is being marketed to the public. It is essential that …